Melissa Adams
Foot & Ankle Surgery · Ada, OKNPI 1285801282
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,372 of the $5,596 with a category attached, or 60.3%. 19 manufacturers reported payments, led by Arthrex at 51.3% of the total. Reporting peaked in 2022 at $3,435 and has fallen 84.3% since, to $539 in 2025.
Across 56 payments — averaging $99.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Pylant Medical$2K
- Stryker$190
- Treace Medical Concepts, Inc.$152
- Integra Lifesciences Corporation$135
- Amgen$132
- plus $535 from 13 others
What the payments were for
- Travel & lodging$3727%
- Food & beverage$1,85233%
- Education$3,37260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 13 | $2,870 |
| Pylant Medical | 10 | $1,581 |
| Stryker | 2 | $190 |
| Treace Medical Concepts, Inc. | 3 | $152 |
| Integra Lifesciences Corporation | 3 | $135 |
| Amgen(2 entities) | 2 | $132 |
| Organogenesis Inc. | 8 | $114 |
| Paragon 28, Inc. | 2 | $109 |
| Fusion Orthopedics USA, LLC | 1 | $87 |
| AstraZeneca | 3 | $44 |
| Johnson & Johnson | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $24 |
| Bioventus LLC | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Kerecis Limited | 1 | $15 |
| KCI USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUGMENT INJECTABLE$140
- Lapiplasty System$120
- KRYSTEXXA$117
How this compares
$5,596 in reported general payments places this provider in the 55th percentile of 71 foot & ankle surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 25 | $957 |
| Duloxetine Hcl | 17 | $162 |
| Terbinafine Hcl | 13 | $148 |
| Meloxicam | 30 | $134 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $62 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Ada
- William SmithShawnee$277K
- Wesley StotlerTulsa$268K
- Andronica HandieTulsa$149K
- Henry SpingolaOklahoma City$48K
- Jessica FaughtOklahoma City$19K
- Brandon KitchensTulsa$19K
- Megan FilkinsEdmond$15K
- James DaviesTulsa$15K
- Shea CharbeneauEdmond$14K
- Matthew CarsonNorman$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.